Christian Lewis

Christian Lewis

Auto-generated profile, based on publicly available information

Christian Lewis

University of Utah, Department of Biomedical Engineering, Salt Lake City, UT

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2024 in Acta Biomaterialia
Verified
Journal Article
Closed access
HLHunter Levis
Hunter Levis
CLChristian Lewis
Christian Lewis
MFMatthew Fainor
Matthew Fainor
ALAmeerah Lawal
Ameerah Lawal
ESElise Stockham
Elise Stockham
RBRobby D. Bowles
Robby D. Bowles

9 October 2026 in Aging Cell
Verified
Journal Article
Open access
PDF file
CLChristian Lewis
Christian Lewis
HLHunter Levis
Hunter Levis
JHJonah Holbrook
Jonah Holbrook
JPJacob T. Polaski
Jacob T. Polaski
TJTimothy D. Jacobsen
Timothy D. Jacobsen
RBRobby D. Bowles
Robby D. Bowles
Senescence has been shown to contribute to the progression of aging‐related diseases including degenerative disc disease (DDD). However, the mechanisms regulating senescence in the intervertebral disc (IVD) and other tissues/diseases remain poorly understood. Recently, ZNF865 (BLST) was identified as a previously uncharacterized zinc finger protein that regulates a wide array of genes related to protein processing, cell senescence, and DNA damage repair. Here, we show that ZNF865 expression decreases with age and pathology in human and mouse IVD samples. Utilizing CRISPR‐guided gene modulation, we show that ZNF865 is necessary for healthy cell function and is a critical protein in regulating senescence and DNA damage in IVD cells, with implications for a wide range of tissues and organs. We also demonstrate that downregulation of ZNF865 induces senescence in asymptomatic human nucleus pulposus (NP) cells. Conversely, restoration in degenerative NP cells mitigates senescence, SASP expression, and DNA damage, enhances ECM anabolism, and restores chromatin accessibility and gene expression to a healthy state. In vivo, CRISPRi of ZNF865 induces disc degeneration and painful behaviors. Collectively, our findings establish ZNF865 as a novel regulator of genome stability and a potential therapeutic target for mediating senescence/DNA damage in aging related diseases.

18 June 2025 in bioRxiv
Verified
Preprint
Open access
CLChristian Lewis
Christian Lewis
HLHunter Levis
Hunter Levis
JHJonah Holbrook
Jonah Holbrook
JPJacob T. Polaski
Jacob T. Polaski
TJTimothy D. Jacobsen
Timothy D. Jacobsen
RBRobby D. Bowles
Robby D. Bowles
Senescence has been shown to contribute to the progression of aging related diseases, yet its regulation in the intervertebral disc (IVD) remains poorly understood. Recently, ZNF865 (BLST) was identified as a previously uncharacterized zinc finger protein, that regulates a wide array of genes related to protein processing, cell senescence and DNA damage repair. Here, we show that ZNF865 expression decreases with age and pathology in human and mouse IVD samples. Depletion of ZNF865 induces senescence, SASP expression and DNA damage in both human and rat healthy NP cells. Conversely, restoration in degenerative NP cells mitigates senescence, SASP expression and DNA damage, enhances ECM anabolism, and restores chromatin accessibility and gene expression to a healthy state. In vivo, CRISPRi of ZNF865 induces disc degeneration and painful behaviors. Collectively, our findings establish ZNF865 as a regulator of genome stability and a potential therapeutic target for mediating senescence/DNA damage in aging related diseases. One Sentence Summary: ZNF865 is a novel modulator of genome stability and senescence and regulates pain outcomes in the intervertebral disc via reversible senescence and DNA damage pathways.